Recently, SDF-1 gene transfer to infracted myocardium was reported to be safe and improved heart failure symptoms in patients with ischemic cardiomyopathies [51], this gives us confidence that SDF-1 gene transfer can also be applied for patients suffering from lung fibrosis. The gene discussed is CXCL12; the disease is pulmonary fibrosis.